Statera Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Statera Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2022.
  • Statera Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $914K, a 8.76% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $914K +$73.6K +8.76% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.06M Jun 30, 2022 10-Q 2022-10-28
Q1 2022 $1.13M Mar 31, 2022 10-Q 2022-10-21
Q4 2021 $964K +$863K +854% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 $841K Sep 30, 2021 10-Q 2021-11-15
Q4 2020 $101K Dec 31, 2020 10-K 2022-10-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.